新生儿接种卡介苗东京-172株后卡介苗所致疾病的临床特征与结局
该研究回顾性分析了泰国曼谷一家三级医疗中心2007年1月至2016年12月收治的95例3岁以下、需医疗关注的卡介苗东京-172株所致疾病患儿,其中疑似25例、可能49例、确诊21例;最常见表现为区域淋巴结炎(87例,92%),5例骨炎,3例播散性感染;作者认为需建立国家监测报告系统。
要点
- 95例卡介苗所致疾病患儿中,区域淋巴结炎87例(92%),骨炎5例(5%),播散性卡介苗3例(3%)。
- 淋巴结炎患儿平均直径2.2 cm(范围0.7-5 cm),53%(46/87)有肺部受累。
- 5例免疫缺陷患儿中3例为播散性卡介苗、2例为淋巴结炎;骨炎患儿均非免疫缺陷宿主。
核心结论
- 区域淋巴结炎是需医疗关注的卡介苗所致疾病最常见表现;所有卡介苗骨炎患儿均非免疫缺陷宿主,提示卡介苗在新生儿中可能存在潜在毒力;需要系统性的国家监测和报告系统来准确估计人群发病率并支持有效疫苗政策的制定。
研究设计与样本
- 回顾性病历回顾研究,纳入2007年1月至2016年12月泰国曼谷一家三级医疗中心经ICD-10编码筛选的3岁以下、发生淋巴结炎、骨炎或播散性感染且卡介苗为可能病原的患儿。
- 病例分类为疑似(临床符合但无实验室确认)、可能(疑似病例且鉴定出结核分枝杆菌复合群)和确诊卡介苗所致疾病(可能病例且分子确认牛分枝杆菌卡介苗株)。
主要发现
- 共纳入95例患儿,男性57例(60.0%),出现症状时中位年龄3.5个月(范围0.6-28.7个月)。
- 疑似25例(26.3%),可能49例(51.6%),确诊21例(22.1%)。
- 区域淋巴结炎87例(92%),骨炎5例(5%),播散性卡介苗3例(3%)。
- 淋巴结炎患儿平均直径2.2 cm(范围0.7-5 cm),53%(46/87)有肺部受累。
- 5例免疫缺陷患儿中,3例为播散性卡介苗,2例为淋巴结炎。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacille Calmette-Guérin (BCG) vaccination at birth may cause mild and benign local adverse effects (AE). More serious AE are rarely reported. OBJECTIVE: To describe clinical features and outcomes of BCG (Tokyo-172 strain)-induce diseases (BCG-ID) that required medical attention at a tertiary care center in Bangkok, Thailand. METHOD: We retrospectively reviewed medical records from January 2007 to December 2016 that were selected by ICD-10 codes. The inclusion criteria were the patients under 3 years of age who developed lymphadenitis, osteitis, or disseminated infections of which BCG was a possible pathogen. Cases were classified into suspected (clinically compatible without laboratory confirmation), probable (suspected cases with M. tuberculosis complex identified), and confirmed BCG-ID (probable cases with molecular confirmation of M. bovis BCG strain). RESULTS: 95 children were identified; 57 (60.0%) were male, and the median age at presenting symptom was 3.5 (range: 0.6-28.7) months. Of these, 25 (26.3%) were suspected, 49 (51.6%) were probable, and 21 (22.1%) were confirmed BCG-ID. Overall, 87 (92%) children had regional lymphadenitis corresponding to the BCG site, 5 (5%) had osteitis, and 3 (3%) had disseminated BCG. Of those with lymphadenitis, average size was 2.2 (range 0.7-5) cm. in diameter and 53% (46/87) had pulmonary involvement. Five children with immunodeficiency; three had disseminated BCG and two had lymphadenitis. Eight (9.2%) patients with lymphadenitis underwent needle aspiration; 57 (65.5%) had surgical excision. All children with BCG osteitis underwent surgical intervention in combination with anti-tuberculosis treatment. One patient with osteitis experienced long-term leg length discrepancy. CONCLUSION: Regional lymphadenitis was the most common feature of BCG-ID requiring medical attention. That none of the BCG osteitis were immunocompromised hosts suggested the potential virulence of BCG in neonates. A systematic national surveillance and reporting system is needed to develop accurate estimates of population incidence and support development of effective vaccine policy.
引用
- Rermruay R, Rungmaitree S, Chatpornvorarux S, et al. Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization. Vaccine. 2018. PMID: 29859799. doi:10.1016/j.vaccine.2018.05.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。